Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PJP
- Price
- 93.43
- Stock movement up
- +- (%)
- Company name
- Invesco Dynamic Pharmaceuticals ETF
- Exchange
- (NYSE ARCA ,
- Currency
- USD )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 1.01%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 7.11%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-10-31
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 0.94 |
| Dividend yield | 1.01% |
| Payout frequency | Quarterly |
| Maximum yield | 1.46% |
| Average yield | 1.21% |
| Minimum yield | 0.99% |
| Discount to avg yield | -19.99% |
| Upside potential | -16.66% |
| Yield as % of max yield | 69.02% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 1.01% |
| Current yield distribution | 94.14% |
| Yield at 100% (Min) | 0.99% |
| Yield at 90% | 1.02% |
| Yield at 80% | 1.03% |
| Yield at 50% (Median) | 1.27% |
| Yield at 20% | 1.34% |
| Yield at 10% | 1.37% |
| Yield at 0% (Max) | 1.46% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | - |
| Dividend per share | 0.94 |
| Payout frequency | Quarterly |
| Ex-div date | 22 Sep 2025 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| PJP | S&P500 | |
| DGR MR | -13.55% | -13.74% |
| DGR TTM | 20.73% | 6.60% |
| DGR 3 years | - | 5.24% |
| DGR 5 years | - | 5.40% |
| DGR 10 years | - | 7.07% |
| DGR 15 years | - | 6.12% |
| Time since last change announced | 300 days |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 93.79 |
| Daily high | 94.23 |
| Daily low | 93.24 |
| Daily Volume | 6K |
| All-time high | 95.65 |
| 1y analyst estimate | - |
| Beta | 0.64 |
| EPS (TTM) | - |
| Dividend per share | 0.94 |
| Ex-div date | 22 Sep 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PJP | S&P500 | |
| Current price drop from All-time high | -2.32% | -1.85% |
| Highest price drop | -16.76% | -19.00% |
| Date of highest drop | 10 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -5.75% | -2.76% |
| Avg time to new high | 23 days | 5 days |
| Max time to new high | 190 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
-
Marketcap category
Description
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Employees
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page